The trials are commencing after the Drugs Controller General of India’s (DCGI) nod for the Phase 2 and 3 clinical trials of Covaxin on children.
The All India Institute of Medical Science (AIIMS), Delhi, will start screening children for clinical trials of Bharat Biotech’s Covaxin from June 7, 2021. This comes days after Bharat Biotech began clinical trials of its Covid-19 vaccine on children aged 2 to 18 years at AIIMS Patna.
The trials are commencing after the Drugs Controller General of India’s (DCGI) nod for the Phase 2 and 3 clinical trials of Covaxin on children.
Covaxin, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is being used in adults in India’s ongoing Covid-19 vaccination drive.
India started the world’s largest vaccination drive on January 16 this year in a phased manner with healthcare workers (HCWs) getting inoculated first. The vaccination of frontline workers (FLWs) started on February 2.
The next phase of Covid-19 vaccination commenced from March 1 for those over 60 years of age and for people aged 45 and above with specified co-morbid conditions. India launched vaccination for all people aged more than 45 from April 1.
The third phase of the vaccination started on May 1 for the beneficiary aged between 18-44.